Biotech ChemT Biotechnology Raises US$5 Million in 18 months to bring AI to Biomanufacturing September 2, 2026
Biotech ChemDiv, Inc. Highlights Successful Deployment of Proprietary CNS Drug Discovery Platform, Advancing Neurodegenerative Programs for Polku Therapeutics and Brenig Therapeutics September 1, 2026
Biotech AbbVie Announces European Commission Approval of MAVIRET® (Glecaprevir/Pibrentasvir) for People with Acute Hepatitis C Virus Infection August 31, 2026
Biotech AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque Psoriasis August 30, 2026
Biotech CPHI/ Hi Korea 2026 Opens Pre-Registration: Korea’s Hub for Pharma, Biopharma, and Health Innovation August 29, 2026
Biotech AH-008 Achieves Dual Regulatory Milestones with U.S. FDA IND Clearance and Taiwan CDE Index Case Designation August 28, 2026
Biotech EQT Life Sciences participates in RQ Bio’s USD 115 million Series A financing August 26, 2026
Biotech Lundbeck presents new Vyepti® (eptinezumab) and bocunebart migraine portfolio data at EAN 2026 August 25, 2026
Biotech Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets August 24, 2026